MedExpress is a UK online prescribing service. Its patients who reported a six-month weight had lost an average of 13.5% from baseline.[1] A separate UK tirzepatide study in women with PCOS also needed follow-up weights to measure change. Reaching six months does not mean a patient recorded a weight.
Who contributed to the weight estimates
The study followed a cohort of 630,545 people who had placed at least two orders. Patients who placed only one order were excluded. At the data cutoff, 611,580 cohort members had started at least six months earlier. Of those, 270,309 (44.2%) had a recorded weight for the six-month analysis. At 12 months, 58,434 of the 202,974 eligible patients (28.8%) had a recorded weight, with average weight loss of 17.4%. Patients entered their own weights. A missing weight does not establish that a patient stopped treatment.[1]
All study authors worked for HeliosX, which sells tirzepatide and semaglutide. The study did not compare the clinic with in-person care or separate the effects of medication, follow-up, and other care. Patients in the least deprived areas placed 26.1% more orders on average than patients in the most deprived areas. The study used area-level deprivation and did not measure each patient’s income.[1]
How follow-up varies by clinic
Before comparing clinics, check how you can contact your clinician between orders. For example, the patient guide for Lavender Sky Health lists telephone and secure-message follow-ups. Those details tell you how to reach that provider. The MedExpress weight-loss figures describe a separate service.[4]
What digital follow-up studies found
In a separate study, patients who engaged more with a digital questionnaire had higher odds of staying on semaglutide at 48 weeks. Patients chose whether to fill it out, so the study could not tell whether the questionnaire itself helped them stay on medication.[2]
An Australian program tracked how many patients had at least six orders fulfilled within 183 days. The raw share rose from 47.3% to 53.2% after the program introduced an AI support tool. The study’s adjusted analysis of medication orders associated the later period with higher odds of attrition. The before-and-after comparison cannot isolate what the support tool did from other changes over time.[3]
Weight reports, continued prescriptions and fulfilled orders measure different things. When comparing clinic claims, check which outcome the program measured and who was included in the reported result.